---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-024723"
form_type: "8-K"
ticker: "OWLT"
cik: "0001816708"
company_name: "Owlet, Inc."
filed_at: "2023-07-11T23:59:59+00:00"
generated_at: "2026-06-13T10:11:56.800286+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Owlet announces NYSE acceptance of compliance plan; cure period extended 18 months

## Summary
- NYSE accepted Owlet's business plan to regain compliance with continued listing standards under Section 802.01B.
- Company has 18-month cure period from April 4, 2023 to meet $50M market cap or stockholders' equity threshold.
- 1-for-14 reverse stock split effective July 7, 2023 to address minimum $1.00 average closing price requirement.
- FDA clearance of BabySat medical pulse-oximetry device cited as growth catalyst.

## SEC filing metadata
- accession: 0001628280-23-024723
- form_type: 8-K
- ticker: OWLT
- cik: 0001816708
- company_name: Owlet, Inc.
- filed_at: 2023-07-11T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816708/000162828023024723/0001628280-23-024723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816708/000162828023024723/owlt-20230711.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-024723
- JSON: https://secwatch.observer/filing/0001628280-23-024723.json
- Plain text: https://secwatch.observer/filing/0001628280-23-024723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.